课题基金 / 基金详情

Virus Receptors and Cytokines

Virus Receptors and Cytokines
病毒受体和细胞因子
批准号:
10044279
负责人:
TASHIRO Kei
金额:
$3.07万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

TASHIRO Kei的其他基金

相似基金

相关文献

中文摘要
翻译
与Verma博士合作(Salk研究所,美国)O 'Brien博士(NCI,美国)Durandy博士(INSERM,法国)及其关于细胞激素的同事,SDF-1,是CXCR 4的天然配体,是T型艾滋病毒的携带者。为了确定我们发现的艾滋病事件集的已知分子机制被推迟,在那些携带SDF 1基因艾滋病延迟型多态性的人身上,血液SDF-1集中在每个个体携带每个基因型都被测量的人身上。因此,新的测量系统命名为SDF-1 TR-FIA是在与松本博士合作开发的(早稻田大学)CREST)和血样是O 'Brien博士收集的。衡量工作仍在进行中.....。在我们的SDF-1表达系统中,CXCR 4在CD 4中D1+ D1细胞在SDF-1中的存在,显示延迟的分子机制。我们正在筛选附加多态性网站与SDF 1基因艾滋病延迟类型多态性网站链接。
英文摘要
Collaboration was done with Dr.Verma (SALK Institute, U.S.A.), Dr.O'Brien (NCI, U.S.A.), Dr. Durandy (INSERM, France) and their colleagues on a cytokine, SDF-1, which is the natural ligand for CXCR4, the coreceptor for T tropic HIV virus.1. To understand molecular mechanism of our finding that AIDS onset is delayed in the persons who bear homozygous alleles of SDF1 gene AIDS delaying type polymorphysm, the blood SDF-1 concentration in each individuals bearing each genotype was measured. For that, new measuring system named SDF-1 TR-FIA was developed in collaboration with Dr.Matsumoto (Waseda Univ./CREST) and blood samples were collected by Dr.O'Brien. The measuring work is still on going.2. In our SDF-1 expression system in vivo, CXCR4 on CD4ィイD1+ィエD1 cells were down-modulated in the presence of excess amount of SDF-1, showing the molecular mechanism of the delay.3. We are screening additional polymorphic site linked with the SDF1 gene AIDS delaying type polymorphysm.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Moriya, C., et. al.: "Large quantity production with extreme convenience of human SDF-1α and SDF-1β by a Sendai virus vector"FEBS Lett.. 425. 105-111 (1998)
Moriya, C., et. al.:“通过仙台病毒载体极其方便地大量生产人类 SDF-1α 和 SDF-1β” FEBS Lett.. 425. 105-111 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Revy,P., et al.: "A Syndrome Involving Intrauterine Growth Retardation, Microcephaly, Cerebellar Hypoplasia. B Lymphocyte Deficiency, and Progressive Pancytopenia"Pediatrics. 105. 22476-22483 (2000)
Revy,P.,等人:“涉及子宫内生长迟缓、小头畸形、小脑发育不全的综合征。B 淋巴细胞缺乏和进行性全血细胞减少症”儿科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Winkler C.et.al.: "Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant"Science. 279. 389-393 (1998)
Winkler C.et.al.:“SDF-1 趋化因子基因变体对艾滋病发病机制的遗传限制”科学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    Gain more insight, perform the following genome-wide association studies in Japanese, counterargument to the study that need correct re-diagnosis by Europe-an study
    • 批准号:
      23659160
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      TASHIRO Kei
    • 依托单位:
    Analysis of molecular mechanisms of inner ear development by characterizing a secreted molecule, OC29, isolated from rat otocyst.
    Isolation and characterization of stem cell-derived neural stem/progenitor cell supporting factor, SDNSF.
    • 批准号:
      13470036
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2001
    • 负责人:
      TASHIRO Kei
    • 依托单位:
    The Complete Nucleotide Sequence of the Human Immunoglobulin Heavy Chain Variable Region Locus
    • 批准号:
      09670335
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      1997
    • 负责人:
      TASHIRO Kei
    • 依托单位:
    国内基金
    海外基金
    固本消积颗粒通过TIMP-1抑制SDF-1/CXCR3依赖性中性粒细胞募集重塑CRC肝前转移生态位的临床及基础研究
    载BFGF和SDF-1甲壳素水凝胶通过Sirt1/PINK1/parkin信号轴调控线粒体MAMs结构稳定性在SUI中的作用及机制
    • 批准号:
      JCZRLH202602139
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    CGRP通过调控SDF-1/CXCR4轴改善先天性胫骨假关节的骨代谢失衡及骨愈合机制
    • 批准号:
      2026JJ81835
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘喜平
    • 依托单位:
    基于SDF-1/CXCR4信号通路探讨低强度脉冲超声促进牵张成骨的作用及其机制研究
    • 批准号:
      2026JJ82627
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      阳芬
    • 依托单位: